CPR: organic sales accelerated in Q3 as guidance of around 3% stays intact
CPR reported 9M organic sales growth of 2.9%, with Q3 accelerating to 3.4%, led by aperitifs and tequila. Full-year guidance of about 3% was kept.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, CPR's organic sales rose 2.9% over the first nine months. Growth picked up to 3.4% in the third quarter, with aperitifs and tequila leading the gains.
The company kept its full-year outlook for organic growth of around 3%. It also flagged headwinds from tariffs and currency effects, along with ongoing portfolio disposals.
why it matters
The faster third-quarter growth and the unchanged outlook matter for investors tracking the consumer and spirits sector. Tariffs, currency moves and asset sales remain risks to revenue and margins.
market impact
CPR: faster organic growth and an unchanged outlook support the company's shares
- CPR shares pressure up — faster organic growth and an unchanged outlook support investor sentiment
tags
instruments
sources
- CPR: Organic growth accelerated in Q3 as aperitifs and tequila led; FY guidance was reaffirmed — TradingView, 28 October 2026 at 16:50 UTC
- CPR: Organic sales growth continued, led by aperitifs and tequila; FY guidance held at circa 3% — TradingView, 28 October 2026 at 16:51 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗